MetaCap

EDAP TMS S.A. (FOCL) vs TransMedics Group (TMDX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

EDAP TMS S.A. (FOCL) has outperformed TransMedics Group (TMDX) over the past year, gaining 13.5% versus a loss of 34.9%. Over five years, TMDX leads with a +289.1% price change compared with -53.0% for FOCL. TransMedics Group is the larger company by market cap ($2.96 billion vs $123.2 million), about 24.0 times the size.

TransMedics Group converts more of its revenue into profit, with a net margin of 31.4% versus -41.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FOCL+13.48%TMDX-34.89%
+187%+62%-64%
Nov 21, 20251 yearNov 20, 2026
FOCL-51.49%TMDX+274.07%
+708%+297%-114%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FOCL versus TMDX key metrics
MetricFOCLTMDX
Share price$2.61$85.25
Market cap$123.25M$2.96B
1-day change-7.45%-9.33%
YTD return-20.67%-29.92%
1-year return+13.48%-34.89%
5-year return-52.97%+289.09%
P/E ratio (TTM)—23.23
Forward P/E—34.31
EPS (TTM)$-1.35$3.67
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$70.53M$605.49M
Revenue growth (YoY)+1.63%+37.13%
Net income (latest FY)$-29.25M$190.29M
Gross margin42.54%59.92%
Operating margin-35.01%17.93%
Net margin-41.47%31.43%
52-week high$6.40$156.00
52-week low$2.11$60.11
Distance from 52-week high-59.22%-45.35%
Analyst consensusbuybuy
Avg. price target upside+218.01%+23.70%
Average volume137.30K930.13K
Shares outstanding47.22M34.73M
Employees289898
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TransMedics Group is about 24.0 times larger than EDAP TMS S.A. by market value ($2.96B vs $123.25M).
  • FOCL has outperformed TMDX by 48.4 percentage points over the past year.
  • TransMedics Group is more profitable, keeping 31.4 cents of every revenue dollar as net income versus -41.5 cents for EDAP TMS S.A..
  • TransMedics Group grew revenue faster in its latest fiscal year (+37.13% vs +1.63%).

About EDAP TMS S.A.

FOCL stock →

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 289 employees

About TransMedics Group

TMDX stock →

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 898 employees

FOCL vs TMDX FAQ

Which is bigger, EDAP TMS S.A. or TransMedics Group?

TransMedics Group (TMDX) is larger, with a market capitalization of $2.96B compared with $123.25M for EDAP TMS S.A. (FOCL).

Which stock has performed better over the past year, FOCL or TMDX?

FOCL returned +13.48% over the past 12 months, compared with -34.89% for TMDX (price return, excluding dividends). Past performance does not predict future results.

Are EDAP TMS S.A. and TransMedics Group in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons